White label ELPA - ClinicalTrials.eu

Study of capivasertib tablets in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Capivasertib
Study of Cabozantinib for Patients with Advanced Renal Cell Carcinoma Previously Treated with One Immunotherapy Drug

Not recruiting

2 1 1 1
Investigated diseases:
- Clear cell renal cell carcinoma
Investigated drugs:
- Cabozantinib
Study on Lacosamide and Duloxetine for Patients with Chemotherapy-Induced Neuropathic Pain

Not recruiting

3 1 1 1
Investigated diseases:
- Neuralgia
- Polyneuropathy
Investigated drugs:
- Duloxetine
- Lacosamide
Study of Hydroxychloroquine Effects in Patients with Resectable Head and Neck Cancer or Non-small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Head and neck cancer
- Non-small cell lung cancer
Investigated drugs:
- Hydroxychloroquine Sulfate
Study Comparing Venetoclax and Obinutuzumab with Drug Combination for Fit Patients with Untreated Chronic Lymphocytic Leukemia Without Specific Genetic Mutations

Not recruiting

3 1 1 1
Investigated diseases:
- Chronic lymphocytic leukaemia
Investigated drugs:
Study of Sasanlimab Treatment as a Bladder-Sparing Strategy in Patients with Muscle Invasive Bladder Cancer

Not recruiting

2 1 1
Investigated diseases:
- Bladder cancer
Investigated drugs:
- Anti-Pdcd1 Igg4 Humanised Monoclonal Antibody
- Sasanlimab
Study on the Effect of Adding Leuprorelin Acetate to Radiotherapy for Patients with Oligo-recurrent Prostate Cancer with Up to 4 Metastases

Not recruiting

3 1 1 1
Investigated diseases:
- Prostate cancer
Investigated drugs:
- Leuprorelin Acetate
Study on the Safety and Effects of AMT-130 for Adults with Early Huntington’s Disease

Not recruiting

2 1 1
Investigated diseases:
- Huntington’s disease
Investigated drugs:
- Ifezuntirgene Inilparvovec
Study on Reduced Dose Intensity of Pembrolizumab and Drug Combination for Patients with Advanced or Metastatic Cancer Responding to Standard Immunotherapy

Not recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
Study of Atezolizumab, Trastuzumab, and Vinorelbine for Patients with Advanced HER2-Positive Breast Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- HER2 positive breast cancer
Investigated drugs:
- Atezolizumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies